AzTrials
AzTrials

Overweight, Obesity Grade ILEXI-MONCT02636335

Light, Exercise Intensity and Mood in Overweight

A study testing Phillips Energy Light HF3319 in people with Overweight, Obesity Grade I, run by University of Basel at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if an exposure to light in the morning has a positive influence on self-chosen exercise intensity on a bicycle ergometer in overweight and obese patients. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Overweight, Obesity Grade I
What is being tested?
Phillips Energy Light HF3319
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteSwitzerland
Study dates
Jan 2016to Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Body Mass Index 25 - 35 kg/m2

Who cannot join

  • Women who are pregnant or breast feeding,
  • Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.),
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Previous enrolment into the current study
  • Participation in other studies in the last four weeks
  • Systolic blood pressure > 170 mmHg, diastolic blood pressure > 100 mmHg
Show all 11Show fewer
  • Shift work in the last two months
  • Travels across time zones in the last four weeks
  • Use of photosensitisation drugs
  • Clinical manifest depression
  • Cardiovascular diseases which reduce age-appropriate exercise capacity

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Departement of Sport, Exercise and Health

    Basel, 4052

Other trials in Switzerland

About this study

The purpose of this study is to determine if an exposure to light in the morning has a positive influence on self-chosen exercise intensity on a bicycle ergometer in overweight and obese patients.

Being tested
Phillips Energy Light HF3319
Medical subject headings
Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Phillips Energy Light HF3319Device

    Exposure to Light administered with Phillips Energy Light HF3319.

Study groups in NCT02636335
Study groupRoleWhat they receive
Bright LightExperimental8 a.m. study participants will be exposed to Bright Light (4500 lx) Phillips Energy Light HF3319 for 30 minutes prior and during a 30 minute lasting exercise test with self-chosen exercise intensity on a bicycle ergometer. The light exposure and time-trial will be performed in three repetitive exercise sessions 48h apart.
Receives: Device: Phillips Energy Light HF3319
ControlExperimental8 a.m. study participants will be exposed to a Control Light Condition (230 lx) Phillips Energy Light HF3319 for 30 minutes prior and during a 30 minute lasting exercise test with self-chosen exercise intensity on a bicycle ergometer. The light exposure and time-trial will be performed in three repetitive exercise sessions 48h apart.
Receives: Device: Phillips Energy Light HF3319

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean power output in watts

    Measured: Power output during the first 30 minute time-trial on a bicycle ergometer.

Secondary outcomes (3)
  1. Subjective sleepiness

    Subjective sleepiness will be measured with the Multidimensional Mood Questionnaire (Category "Wakefulness - Sleepiness")

    Measured: 1 minute after the light exposure vs. 1 minute before the light exposure in the first time trial

  2. Subjective Mood

    Subjective Mood measured with the Multidimensional Mood Questionnaire (Category "Good Mood - Bad Mood")

    Measured: 1 minute after the light exposure vs. 1 minute before the light exposure in the first time trial

  3. Mean power output in watts during the first, second and third time-trial on a bicycle ergometer.

    Measured: Mean of the 30 minutes of the exercise from the first, second and third time-trial.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Dec 2015 (estimated)
  2. Study startJan 2016
  3. Primary completionJun 2017
  4. Study completionJun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02636335
Sponsor's protocol ID
LEXI-MO
Acronym
LEXI-MO
Status last verified
Jun 2017
First submitted
14 Dec 2015
Last updated
29 Jun 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Phillips Energy Light HF3319 in people with Overweight, Obesity Grade I, run by University of Basel at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean power output in watts (time frame: Power output during the first 30 minute time-trial on a bicycle ergometer.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2017; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in